Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands										2 Months Ended	3 Months Ended			6 Months Ended
	Aug. 09, 2024	Jul. 30, 2024	Jul. 09, 2024	Mar. 28, 2024	Dec. 20, 2023	Oct. 03, 2023	Aug. 01, 2023	Jul. 27, 2023	Apr. 08, 2020	Aug. 16, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 26, 2024
Subsequent Event [Line Items]
Offering expenses														$ 1,704	$ 137
Nasdaq minimum bid requirement																$ 1.00
Sales Agreement [Member]
Subsequent Event [Line Items]
Number of shares issued				336,459		126,563		79,062
Offering price				$ 9.60
Offering expenses				$ 500	$ 2,300	$ 500	$ 700
Net proceeds				$ 3,900		$ 4,000	$ 6,300
Sales Agreement [Member] \| Alliance Global Partners [Member]
Subsequent Event [Line Items]
Number of shares issued												13,766			29,855
Net proceeds												$ 1,000			$ 3,000
Offering price per agreement									$ 320,000
Commission to agent									3.00%
Pre-Funded Warrants [Member] \| Sales Agreement [Member]
Subsequent Event [Line Items]
Number of shares for common warramts				121,875		154,687		139,688
Offering price				$ 9.5968		$ 15.99		$ 31.99
Subsequent Event [Member]
Subsequent Event [Line Items]
Offering expenses			$ 500
Placement Agent Fees			300
Net proceeds			$ 3,500
Period of business days of non-compliance with minimum bid requirement	30 days
Nasdaq minimum bid requirement	$ 1
Period to regain compiance with minimum bid requirement	180 days
Additional period to regain compiance with minimum bid requirement	180 days
Subsequent Event [Member] \| Sales Agreement [Member] \| Alliance Global Partners [Member]
Subsequent Event [Line Items]
Number of shares issued										800,000
Net proceeds										$ 400
Offering price per agreement		$ 50,000
Commission to agent		3.00%
Subsequent Event [Member] \| Pre-Funded Warrants [Member]
Subsequent Event [Line Items]
Number of shares for common warramts			3,703,140
Offering price			$ 0.5699
Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued											4,369,807	13,766	16,089
Common Stock [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares issued			3,393,600
Offering price			$ 0.57